Clover Health Investments Corp. Cl A (CLOV) News

Clover Health Investments Corp. Cl A (CLOV): $3.21

-0.04 (-1.23%)

POWR Rating

Component Grades













Filter CLOV News Items

CLOV News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CLOV News Highlights

  • For CLOV, its 30 day story count is now at 6.
  • Over the past 28 days, the trend for CLOV's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • CMS, CTO and DRUG are the most mentioned tickers in articles about CLOV.

Latest CLOV News From Around the Web

Below are the latest news stories about Clover Health Investments Corp that investors may wish to consider to help them evaluate CLOV as an investment opportunity.

Clover Health Investments, Corp. (CLOV) CEO Vivek Garipalli on Q4 2021 Results - Earnings Call Transcript

Clover Health Investments, Corp. (CLOV) Q4 2021 Earnings Conference Call February 23, 2022, 05:00 PM ET Company Participants Derrick Nueman - VP of IR Vivek Garipalli - CEO Andrew Toy - President and CTO Mark Herbers - CFO Conference Call Participants Richard Close - Canaccord Genuity Jonathan Yong - Credit...

SA Transcripts on Seeking Alpha | February 24, 2022

Clover Health Gains 14.9% on Higher Q4 Revenues

Clover Health (CLOV) has delivered a stellar performance in the fourth quarter of 2021, as both earnings and revenues exceeded expectations. Shares of the next-generation healthcare company have rallied 14.9% in Wednesday’s extended trading session to close at $2.31. Total revenues of $432 million surpassed analysts’ expectations of $408.1 million. The company had reported total revenues of $166.2 million in the fourth quarter of 2020. Markedly, revenues consist of $201 million in premiums earned and $228.6 million of Direct Contracting revenue. As of December 31, 2021, while lives under Clover Management were about 129,996, up 124% year-over-year, lives under Clover Assistant Management grew 223% to about 96,000.

Radhika Saraogi on TipRanks | February 24, 2022

7 Popular Stocks That Pros Agree You Should Punt From Your Portfolio

These stocks to sell run the gamut in terms of industry, but they all have one thing in common: the pros think they ought to be sold.

Alex Sirois on InvestorPlace | February 23, 2022

Is CLOV Stock a Buy at 52-Week Lows? 3 Analysts Weigh In on Clover Health.

Here's what some expert analysts think about Clover Health and CLOV stock amid the stock's impressive decline to new 52-week lows.

Chris MacDonald on InvestorPlace | February 23, 2022

Clover Health Reports Fourth Quarter 2021 Financial Results

Fourth quarter total revenue was $432.0 million, up 160% year-over-year, enabled by a wide, open network designed to serve all Medicare lives Lives under Clover Assistant Management increased 223% year-over-year 2022 total revenue expected to exceed $3 billion driven by projected 90% year-over-year growth in lives under management Clover expects 2022 operating expenses as a percentage of revenue and the Medical Care Ratio (MCR) for its Medicare Advantage (MA) plans to decrease meaningfully from

Yahoo | February 23, 2022

IPOF Stock Keeps Heating Up as SpaceX SPAC Merger Rumors Persist

After Chamath Palihapitiya stepped down from Virgin Galactic's board, investors are speculating that IPOF stock may merge with SpaceX.

Eddie Pan on InvestorPlace | February 22, 2022

5 Upcoming SPACs to Watch in 2022

DWAC stock should help reignite the blank-check bubble in 2022.

Samuel O'Brient on InvestorPlace | February 16, 2022

Clover Health to Present at Citi's 2022 Virtual Healthcare Conference on February 24, 2022

FRANKLIN, Tenn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), a technology company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, and President, Andrew Toy, will present at Citi's 2022 Virtual Healthcare Conference on Thursday, February 24, 2022, at 2:45 p.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website at An archived rep

Yahoo | February 10, 2022

A Buyout May Be the Best Hope for Clover Health Now

The situation behind CLOV stock is spiraling from bad to worse.

Ian Bezek on InvestorPlace | February 8, 2022

10 Fintech Stocks To Own Until 2032 and Beyond

While falling out of favor for now, in the long-term the 'digitalization of money' trend could send these 10 fintech stocks higher.

Thomas Niel on InvestorPlace | February 8, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8768 seconds.